October 2024

Boss Energy (ASX:BOE) has delivered a strong Q3 FY24 performance, with its Honeymoon Uranium Project in South Australia producing 89,516 lbs of U3O8, marking a significant ramp-up from the previous quarter’s 28,844 lb. This increase was driven by the successful operation of two production columns, with a third column on track for commissioning in December […]

29Metals (ASX:29M) posted a mixed performance in Q3 FY24, with zinc production at its flagship Golden Grove mine soaring 25% quarter-on-quarter to 19.1kt. However, copper production dropped to 4.4kt. Despite the operational challenges, the company’s free cash flow amounted to $26m for the quarter, with operating cash flow reaching $42m. James Palmer, 29Metals’ CEO, commented

To register for Friday’s webinar click here. Eastern Metals Ltd (ASX:EMS) has reported promising initial assay results from its recent reconnaissance drilling at the Cobar Project in NSW. Drilling at the new targets Kelpie Hill and Windmill Dam, as well as the more advanced Evergreen prospect, has yielded results from three holes at Kelpie Hill.

At 11:50am, the S&P/ASX 200 is 0.18 per cent higher at 8,221. The SPI futures are pointing to a rise of 7 points. Best and worst performers The best-performing sector is Consumer Staples, up 1.25 per cent. The worst-performing sector is Information Technology, down 0.76 per cent. The best-performing large cap is Qantas Airways (ASX:QAN),

The S&P 500 and the Dow Jones Industrial Average finished Tuesday marginally lower, as investors grappled with ongoing concerns about a potential rise in interest rates and processed this week’s latest earnings reports. The S&P 500 closed down 0.05 per cent, finishing at 5,851.20. This marked the broad market index’s first consecutive loss since early

Over the past year, the price of gold has experienced something unusual. It has reached record highs, seemingly disconnected from traditional influencers like interest rates, inflation, and the dollar. Even more striking is its steady ascent, which stands in contrast to the volatility of major geopolitical events. Gold’s status as a “safe-haven” asset has evolved,

Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses investing mistakes. Key pointsMany of the mistakes investors make are based on common sense rules of thumb that turn out to be wrong.As a result, it’s often wise for investors to turn common sense logic on its head.The easiest way to avoid

Immutep (ASX:IMM) has released its annual report, detailing significant progress over the past year with its lead immunotherapy candidate eftilagimod alpha (efti). This drug is designed to activate the body’s immune system to better recognise and attack cancer cells. It targets LAG-3, a protein that plays a key role in regulating immune responses. Specifically, efti

Australian semiconductor company BluGlass (ASX:BLG) has entered into a promising multi-phase Joint Development Agreement (JDA) with Uviquity, a US-based venture-backed start-up. The first phase of this agreement, valued at A$1.2 million, involves the development of advanced photonic chips. This collaboration aims to integrate BluGlass’ expertise in gallium nitride (GaN) laser technology with Uviquity’s innovations in

Medical technology company ImpediMed (ASX:IPD) continues to make strides with its SOZO® Digital Health Platform, reporting significant progress in its Q1 FY25 results. The company’s pipeline for SOZO units increased by 34%, with 28 units sold in the US, a notable rise from the previous quarter’s 23 units. SOZO, which uses bioimpedance spectroscopy (BIS), is